Stock listing

REG Stock Price, News, Filings & Events — Remegen Co. Ltd. Class A

Selected listing: REG · SWB · EUR · DE

The selected listing for Remegen Co. Ltd. Class A is REG:SWB. The company is focused on developing innovative therapies for cancer treatment, with a strong emphasis on monoclonal antibodies. Recent news highlights their ongoing clinical trials and advancements in drug development. Investors can find the latest filings and upcoming events related to the company's progress in the biopharmaceutical sector. The market context reflects growing interest in oncology solutions, positioning Remegen as a key player in this field.